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A COMPARISON OF THE ILLUMINA MISEQ FGX™ SYSTEM AGAINST 
CAPILLARY ELECTROPHORESIS IN THE ANALYSIS OF TWO-PERSON 
MIXTURES 
 
DAVID PATRICK MCEVOY 
 
ABSTRACT 
The following is a comparison study of the Globalfiler™ PCR Amplification Kit 
analyzed on an ABI 3130 Genetic Analyzer Capillary Electrophoresis (CE) versus the 
ForenSeq™ DNA Signature Prep Kit analyzed on the MiSeq FGx™ System.  The MiSeq 
FGx™ System measures results by Allele Read Count (ARC), while the CE measures 
results as Relative Fluorescent Units (RFU).  Mixture samples were prepared in ratios of 
1:1, 1:4, and 1:10 in replicates of four using a female major contributor and a male minor 
contributor, intended to represent some commonly seen mixture samples ratios in forensic 
cases [48].  Both systems performed equally well for the 1:1 mixture while the MiSeq 
FGx™ System had improved accuracy and precision for the 1:4 mixture compared to CE 
(4.033 + 1.506 ARC and 4.678 + 2.093 RFU, respectively).  The MiSeq FGx™ System 
showed increased variation in the 1:10 mixture compared to CE (10.347 + 5.184 ARC and 
9.311 + 3.363 RFU, respectively).  Over the four replicates, the MiSeq FGx™ System had 
a total of 15 out of 528 possible alleles (2.84%) dropout compared to a total of 13 out of 
384 possible alleles (3.39%) dropout on CE.  The additional loci analyzed by the MiSeq 
FGx™ System results in a lower percentage of alleles lost due to dropout compared to CE.   
Isoalleles in sequence data may reveal the presence of minor contributor alleles that 
would otherwise be masked by the major contributor in length-based STR analysis.  The 
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presence of isoalleles are most helpful in mixture ratios greater than 1:1, where it is easier 
to assign alleles to a specific contributor.  In certain cases, deconvolution of loci with 
shared alleles may not be improved by sequencing if intra-contributor isoalleles are present.  
Unless using known reference profiles, it is difficult to accurately assign alleles to 
contributors when intra-contributor isoalleles are present.  Additionally, the sequencing 
data from the MiSeq FGx™ System provided information to aid the separation of stutter 
from true alleles.  Previous studies report a significant increase in the amount of alleles 
present at some loci due to differences by nucleotide sequence, which may improve the 
discriminating power of those loci [31,52,53,54].  With all its potential, there is still much 
room for sequencing technology to improve before it becomes a standard analysis method 
in forensic laboratories. 
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1. INTRODUCTION
1.1 Structure and Function of DNA 
Deoxyribonucleic acid (DNA) is the molecular blueprint for all living creatures, 
providing the information for everything from the function of their cells to their outward 
physical appearance.  It encodes the genetic information passed down from parents to an 
individual offspring.  Human DNA was first discovered and isolated from human 
leucocytes by Friedrich Miescher in 1869 [1].  It was not until 1953 that the structure of 
DNA was first described by James Watson and Francis Crick and shown to form a double 
helix structure, or two strands of DNA bound together to resemble a twisting ladder [2].   
The sides of the ladder are made up of sugar and phosphate groups, while the rungs 
of the ladder are held together by pairs of the four nucleotides, or bases:  Adenine (A), 
Thymine (T), Guanine (G), and Cytosine (C).  The opposite strands are complimentary to 
one another, held together by either double hydrogen bonds (A-T) or triple hydrogen bonds 
(G-C) [2].   
The human genome consists of 23 pairs of chromosomes containing roughly 6 
billion base pairs [3].  Coding regions of DNA provide instructions for the synthesis of 
proteins through the process of translation and transcription.  Some of the functions of the 
noncoding regions include regulation of proteins synthesis, synthesis of functional 
ribonucleic acids (RNA), or maintaining the structure of DNA.  Human DNA is mostly 
made up of the noncoding regions, with coding regions interspersed throughout [4].   
In the noncoding regions there are repeat units of nucleotides known as tandem 
repeats, which can be polymorphic.  Coding regions can also have polymorphisms, but 
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noncoding regions contain a significantly larger quantity of polymorphisms [4,5].  Types 
of DNA polymorphisms are by sequence or length, including single nucleotide 
polymorphisms (SNP) [6].  Two types of common tandem repeats are minisatellites and 
microsatellites.  A minisatellite, or variable number tandem repeat (VNTR), can have 
repeat unit lengths ranging from several to hundreds of base pairs [7].  A microsatellite, or 
short tandem repeat (STR), has repeat unit lengths of 2-6 base pairs [8,9].  Most of the core 
STR loci used in modern DNA typing have tetranucleotides, and a few STR loci that have 
tri- or pentanucleotides [10].   
Alternate forms of polymorphisms at a single locus are known as alleles.  A single 
locus can be highly polymorphic, meaning it has many different possible alleles that vary 
by length and/or sequence.  For example, a segment of nucleotides (AATG) that have 8 
repeats [AATG]8 is known as the 8 allele at that locus, but another allele could have 10 
repeats [AATG]10 [11,12].  Forensic DNA analysis utilizes the properties of DNA 
polymorphisms at multiple locations on the genome to identify and discriminate 
individuals based on the allele combinations that make up their genotype [13]. 
1.2 Forensic DNA Analysis 
Forensic DNA analysis has been continuously evolving since its inception.  In 1977 
[14], Frederick Sanger developed the chain termination method of DNA sequencing using 
dideoxynucleotide triphosphates (ddNTPs) that came to be known as Sanger sequencing.  
This dideoxy sequencing method paved the way for future sequencing and DNA typing 
technologies.  In 1984, Alec Jeffreys et al. invented a technique for DNA fingerprinting by 
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targeting restriction fragment-length polymorphisms (RFLPs) and VNTRs with the use of 
the Edwin Southern’s Southern Blot technique [15,16].  The technique was first used in 
forensic DNA analysis in 1985 by isolating DNA from four-year-old blood and semen 
stains on cotton to generate DNA profiles for individual identification.  The separation of 
male sperm from female vaginal cells from sexual assault samples is known as differential 
extraction and it is useful for the identification of male suspects [17]. 
Kary Mullis’s invention of the polymerase chain reaction (PCR) was introduced in 
1985 [18], which enabled the analysis of minute quantities of DNA that would otherwise 
not provide enough information for forensic analysis.  PCR is an amplification technique 
that exponentially increases the amount of double-stranded DNA with the use of a template 
DNA strand, oligonucleotide primers, deoxynucleotide triphosphates (dNTPs), and 
thermostable DNA polymerases [19].  The forward and reverse primers identify the region 
of the template strand that the polymerase will copy, and the dNTPs supply each of the 
four nucleotides (A, T, C, G) that the polymerase uses to copy the template strand sequence.  
In the 1990s [20,21,22], laboratories began using PCR amplification of STRs as they are 
more amenable to PCR than VNTRs which are too long to efficiently copy using PCR. 
Their shorter lengths also make STRs better for analyzing degraded DNA and less 
susceptible to preferential amplification.  Furthermore, PCR allows for the amplification 
of multiple STR templates at once, referred to as multiplexing. 
The introduction of capillary electrophoresis (CE) in the 1990s [23,24] further 
improved the efficiency of DNA typing by replacing gel electrophoresis with automation 
of the separation and analysis of fluorescently tagged STR fragments.  CE separation and 
4 
typing of PCR amplified STR loci has been the gold standard of forensic DNA analysis 
since the early ‘90s, with the catalog of STR loci in commercial amplification kits 
continuously growing in the following decades.  STR loci were chosen based on their 
power of discrimination, low rates of PCR artifacts, low mutation rates, being well suited 
for degraded samples, and either being on separate chromosomes or having enough space 
between them on the same chromosome to exclude any possible linkage [25].  However, 
in the past decade, the application of sequencing to forensic science has made a resurgence 
with the advancement of new technologies. 
1.2.1 Capillary Electrophoresis 
Current methods of forensic DNA analysis begin with the extraction and 
purification of DNA from samples, which are then quantified to determine the amount of 
human DNA present in the sample [26].  Quantification is essential to ensure that the 
appropriate amount of sample is being added to the PCR reaction to prevent artifacts that 
make interpretation of DNA profiles more challenging [27].  After the DNA has been 
amplified by PCR, the amplicons are separated by size and typed using the CE [26]. 
Amplified DNA products are denatured either with heat, formamide, or both, to 
ensure proper separation of DNA into single-stranded DNA (ssDNA) and then 
electrokinetically injected into the polymer-containing capillary.  DNA molecules are 
negatively charged in an aqueous solution of neutral pH, so a short application of current 
is used to facilitate entry of the ssDNA into the capillary.  Once in the capillary, an electric 
current is applied, and the DNA will travel from the anode at the start of the capillary to 
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the cathode at the end.  Smaller fragments of DNA will travel faster than the larger 
fragments and will be detected first.  Detection of fragments is performed with the use of 
an excitation laser that will excite the fluorescently labelled fragments; the light given off 
by the labels will be captured by a charge-coupled device (CCD) camera as relative 
fluorescent units (RFUs).  The allelic data captured by the camera is visualized as peaks on 
an electropherogram (EPG) [26].  Higher concentrations of DNA fragments produce more 
intense light emission, translated to larger RFUs and visualized as higher peak heights (PH) 
on the EPG [13].  
The time taken by a DNA fragment to be detected by the CCD camera is compared against 
a size standard and an allelic ladder.  The size standard will inform the computer of the 
time necessary for a certain sized molecule, in base pairs (bp), to travel through the 
capillary.  The allelic ladder is a sample of known allele fragments; the time necessary for 
the known alleles to travel through the capillary and be detected by the CCD camera is 
compared to the time detected for each size standard fragment.  Because specific alleles 
are known to have specific bp sizes, the computer may now compare sample DNA 
fragment detection times against the standards to determine the bp size of the sample, and 
therefore the allele determination for sample peaks can be made [26].  
Visualization of the data in EPGs can be optimized with laboratory validated 
thresholds, such as analytical and stochastic thresholds (AT and ST, respectively), but 
issues with interpretation of STR profiles are common.  Artifacts from PCR, CE, and 
insufficient DNA are seen as stutter, allele dropout or drop in, pull-up, spikes, or PH 
imbalance.  Artifacts such as pull-up and spikes are specific to errors in the CE, whereas 
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stutter occurs during PCR.  The observation of PH imbalance and allele dropout or drop in 
may occur from errors in PCR or due to low quantity/quality DNA sample [26].  Many of 
these artifacts are exacerbated in mixed STR profiles.  The Scientific Working Group on 
DNA Analysis Methods (SWGDAM) continuously improves and releases guidelines for 
the interpretation of STR profiles [13,28].  
1.2.2 Sanger Sequencing 
Sanger sequencing, described above as a method for DNA sequencing using chain-
terminating ddNTPs, is a lengthy process because the DNA needs to be fragmented into 
smaller segments and cloned using bacteria before each fragment can be separated into 
four separate reactions for each template fragment and then run on a polyacrylamide gel 
with electrophoresis [3].  The template is aliquoted into four separate tubes, each with 
labelled primers, DNA polymerase, and each of the four dNTPs (dATP, dTTP, dCTP, 
dGTP).  Each of the tubes is then given only one of the four chain-terminating ddNTPs 
(ddATP, ddTTP, ddCTP, ddGTP) that would terminate the chain elongation reaction 
randomly at different points, resulting in various lengths of DNA fragments that would 
reveal the sequence of the template strand after manually reading of gel electrophoresis 
[29].  The introduction of fluorescently dye-labelled ddNTPs allowed for the reaction to be 
performed in a single tube, rather than four, and enabled optical sequence reading by a 
computer [30]. 
Sanger sequencing was initially the sequencing method used by the US Human 
Genome Project in 1990 to sequence the entire human genome; spending the next 11 years 
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developing the first draft of the sequenced human genome, finally concluding in 2003 with 
a final draft of the completely sequenced human genome [3].  By 1998, only 5% of the 
human genome was sequenced using this method while when whole-genome shotgun 
sequencing was implemented the first draft of the genome was completed within a year [3].  
1.2.3 Next Generation Sequencing 
Sanger sequencing of STRs is time consuming and cost inefficient to be practical 
in forensic science, as heterozygous alleles must be physically separated prior to 
sequencing and loci cannot be multiplexed [31].  CE-based STR analysis is robust and 
reliable, and has been the backbone of forensic DNA analysis since the late 1990s, but has 
some limitations as well.  CE-based STR analysis enables the multiplex of up to 30 STR 
loci.  Although, CE is unable to differentiate alleles or stutter when they have equal lengths 
because it separates alleles based solely on differences in length [32].  Comparatively, the 
technique of massively parallel sequencing (MPS), also known as Next Generation 
Sequencing (NGS), can sequence thousands of genomic regions in a single reaction.  In 
2008, an accurate whole human genome sequence was completed in 8 weeks using 
reversible terminator chemistry and MPS [33], compared to a year that it took to complete 
the same task using whole-genome shotgun sequencing [3].  Furthermore, it offers an 
additional degree of discrimination than CE-based methods because NGS has the ability to 
separate alleles based on their sequence as well as their length [33]. 
Many new alleles have been defined through sequencing, revealing some STR loci 
to be more polymorphic, and thus, more informative, than when detected by CE analysis. 
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Independent studies using varying STR amplification kits and sequencing technologies 
have revealed increases in variability when analyzing sequences rather than just length. 
The data is mostly congruent, with slight variation in the results obtained from certain loci. 
Some studies have showed novel alleles at certain loci, while other studies failed to observe 
any variation at the same loci.  This lack of agreement may be due to the ability to only 
view the repeat region (RR) and not the flanking region (FR), dependent on the data 
analysis software, sequencing platform, or by primers not covering a large enough portion 
of the FR [32]. 
Sanger sequencing has all but been replaced by NGS in many fields, including 
clinical, as it can target specific genes responsible for diseases to be used as a diagnostic 
test [34].  It is a technological breakthrough in the field of molecular biology and continues 
to grow exponentially as companies compete to offer increased throughput while 
decreasing time and cost to perform analysis.  Application to forensic samples has already 
been demonstrated, as has the reliability of NGS in the analysis of STR loci as library 
preparation methods continue to advance [33]. 
1.3 Mixture Samples 
With the improvement of DNA technology and CE chemistry that allows for more 
sensitive detection of DNA, mixture profiles have become more prevalent [35].  Evidence 
samples that contain more than one contributor’s DNA can affect an analyst’s 
interpretation of results as many problems can arise in the interpretation of mixed DNA 
profiles.  Improvements in mixture deconvolution have been introduced to the field of 
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DNA analysis in recent years [36], and there is always room for advancement.  The current 
steps for mixture deconvolution include the comparison against known profiles, calculation 
of contributor ratio, combined probability of inclusion (CPI), random match probability 
(RMP), likelihood ratio (LR), or use of probabilistic genotyping methods [13,37,38].  The 
presence of allele sharing and allele dropout at individual loci can severely hinder the 
calculation of the number of possible contributors and the allele sharing issue becomes 
increasingly prevalent as the number of contributors increases [39,40,41].  Previous studies 
[39,42] have shown that highly polymorphic loci provide more information and increasing 
the number of loci tested improves the accuracy of contributor estimates in two-person 
mixtures. 
As previously stated, NGS can separate alleles based on their sequence.  A mixture 
of two people that share an allele at a locus can have alleles of different sequences, 
therefore improving estimations of the number of contributors and possibly aiding an 
analyst in determining which individual the sequence belongs to.  The ability to view the 
sequence can also provide the ability to determine if a peak is stutter or a true allele 
belonging to a specific contributor, when sequence differences are present.  Sequence data 
has the potential to reduce the ambiguity of shared alleles and stutter peaks when 
determining the maximum allele count (MAC), making mixture deconvolution a simpler 
process, even in 1:1 mixture ratios. 
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1.4 ForenSeq™ DNA Signature Prep Kit and MiSeq FGx™ System 
The MiSeq FGx™ system (Illumina) utilizes the sequencing by synthesis (SBS) 
method to generate genotypic data for up to 96 database samples and 32 casework samples 
in a single run, using fluorescently labeled ddNTPs on clonally amplified DNA templates 
attached to specialized flow cell [43].  With each cycle of the run a single fluorescently 
labeled ddNTP is added to the template strand and the CCD captures the color of the added 
nucleotide.  The MiSeq FGx™ runs for a total of 398 sequencing cycles consisting of 4 
reads (Read 1, Index 1, Index 2, and Read 2).  Read 1 is 351 cycles that sequences the first 
351 bases of the template strands.  Index 1 and Index 2 are both 8 cycles to determine the 
sample designations by sequencing the i7 index and i5 index adaptors, respectively.  Read 
2 sequences the last 31 nucleotides of the amplicons in the reverse direction of Read 1 to 
aid in sequence alignment and to sequence any amplicons longer that 351 bp.  The 
Universal Analysis Software (UAS) that works in conjunction with the MiSeq FGx™ 
analyzes the images taken by the CCD camera in real time, calls bases, and assigns a quality 
score to each base call. 
The UAS also provides quality metrics on each run, reporting information on the 
positive and negative controls, cluster density, clusters passing filter, phasing, and 
prephasing.  Cluster density is the number of clusters that have been generated on the flow 
cell per square millimeter and has a recommended target range of 400–1650 K/mm².  Based 
on the Illumina chastity filter, the percentage of clusters passing filter measures quality and 
can detect low quality base calls, with an optimal range of ≥ 80% of clusters passing the 
filter.  Phasing is the percentage of molecules in a cluster that fall behind the current cycle, 
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while prephasing is the percentage of molecules in a cluster that run ahead of the current 
cycle.  Phasing and prephasing metrics have optimal values at ≤ 0.25% and ≤ 0.15%, 
respectively.  Values outside of optimal ranges for many of the above mentioned quality 
metrics can still produce sufficient results for analysis, but values that deviate substantially 
from the optimal range can negatively impact other quality metrics and run data.  At the 
completion of the run, the UAS uses the real time data obtained during the run to align 
reads and to make allele and genotype calls.  Rather than measuring how intense the 
fluorescence is as RFU, the MiSeq FGx™ software measures intensity by the number of 
times an allele was read by the camera, referred to as Allele Read Count (ARC) [44]. 
Just as CE-based analysis software has ATs and STs, the UAS has ATs and 
interpretation thresholds (IT) for each locus.  The AT is the lower limit of detection, 
anything below is not called as an allele, and the IT acts as a conservative allele calling 
threshold.  The AT and IT are defined by percentages of 1.5% and 4.5% of reads, 
respectfully, preset on the UAS by Verogen’s internal validation studies.  CE-based 
analysis generally uses the same AT and ST values across all loci, but due to the UAS’s 
use of percentages, the values of the AT and IT will vary between loci and samples.  The 
UAS also uses various percentages, similarly to CE-based analysis, for filtering stutter and 
varies for each locus.  The threshold and stutter percentages may be manually changed by 
an analyst based on a laboratory’s internal validation of the software [44]. 
Compared to the Globalfiler™ amplification kit of 24 STR loci targets, Verogen’s 
ForenSeq™ DNA Signature Prep Kit A provides information on 27 autosomal STRs, as 
well as an additional 7 X-STRs, 24 Y-STRs, and 94 identity-informative SNPs in a single 
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run.  The amplification of 152 markers on MiSeq FGx™ corresponds to approximately a 
534% increase in mean total number of markers amplified by Globalfiler™ on CE, or 
approximately a 28.5% increase if only considering autosomal STRs.  The additional six 
autosomal STRs alone may aid in mixture deconvolution compared to the 21 loci in the 
Globalfiler™ kit.  When compared to two other NGS technologies, the MiSeq FGx™ had 
the second-best rate of calling correct SNPs but had the fewest false positives [43].  Based 
on this previous research, an optimized MiSeq FGx™ provides the best results for the time 
and cost required to generate data. 
1.5 Objective 
With an increase in sensitivity of DNA analysis technology, the likelihood of 
obtaining mixture profiles has also increased, and thus, the need for more specificity in 
analysis.  This study will compare the MiSeq FGx™ System against current CE-based 
analysis in their ability to assist in the analysis of two-person mixture samples at various 
contributor ratios.  It is expected that the addition of sequencing data to STR analysis will 
provide additional criteria to discern contributors from one another.  To highlight the 
benefits of sequencing, this study will place emphasis on the STR loci that are shared 
between the two kits, one commonly used in CE STR analysis and one designed for DNA 
sequence analysis on the Illumina MiSeq FGx™ System. 
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2. MATERIALS AND METHODS
Saliva samples on sterile cotton swabs were obtained from 21 individuals of a 
family pedigree spanning four generations and were numbered 441 through 461 (Figure 1).  
The samples obtained from the pedigree consists of 10 males and 11 females.  One-third 
of each swab, including reagent blanks for each run, was extracted in 100 microliters (ul) 
TE buffer using the Qiagen EZ1 Advanced DNA Investigator Kit, following the “EZ1 
Advanced DNA Investigator Kit Purification Protocol for Dried Saliva ‘Tip-Dance 
Protocol’.”  This automated protocol allowed for DNA extraction with the swab cutting 
left in the tube. 
Figure 1.  Family pedigree.  21 individuals over four generations labelled 441 
through 461. 
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After extraction, quantification of the purified DNA was performed in duplicate 
using the Quantifiler Duo Kit (Applied Biosystems, Foster City, CA) on a 7500 Real-Time 
PCR (RT-PCR) Instrument (Applied Biosystems, Foster City, CA) using 2 ul of sample, 
according to the manufacturer’s established protocols.  Sample 444 showed large variation 
between duplicates and sample 455 showed little DNA in one duplicate and no DNA in the 
other; sample 455 was re-extracted and both samples were re-quantified, resulting in 
acceptable values.  Concentrations of DNA were determined using a calibrated standard 
curve.  Two CE runs were performed using the Globalfiler™ PCR amplification kit, once 
for the entire pedigree and once for the mixture samples at varying ratios.  The same runs 
were performed on the MiSeq FGx™, a full pedigree run and a run for the mixture samples. 
2.1 Amplification and Capillary Electrophoresis 
Samples 441 – 461 were amplified using the Globalfiler™ PCR Amplification Kit 
(Applied Biosystems, Foster City, CA) on a GeneAmp® PCR System 9700 (Applied 
Biosystems, Foster City, CA), following the Boston University laboratory validated 
“Amplification Using Globalfiler™ Amplification Kit” protocol with an amplification 
target of 0.75 ng.  A positive control of 5 µl DNA Control 007 and a negative control of 5 
µl additional master mix were included in the amplification runs for quality control. 
Parameters for amplification were as follows:  95℃ for 1 minute, 29 cycles of [94℃ for 
10 seconds, 59℃ for 90 seconds], 60℃ for 10 min, then 4℃ indefinitely.  Following the 
“Capillary Electrophoresis using ABI 3130 and Globalfiler™” protocol, 1 µl of each 
sample was added to their respective wells of a 96-well plate, along with a Hi-Di 
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Formamide and Liz 600 internal standard master mix.  In addition, 1 µl of allelic ladder 
was added to the appropriate wells.  The samples were then denatured at 95℃ for 3 minutes 
and then immediately chilled at 4℃ for 3 minutes.  The amplified samples were then 
separated and typed on an ABI 3130 Genetic Analyzer Capillary Electrophoresis (Applied 
Biosystems, Foster City, CA) using Pop-4TM Polymer and a 1.2 kilovolt (kV) injection of 
5 seconds.  Results were analyzed as EPGs using GeneMapper® ID-X version 1.4 with 
stutter filter on and an AT of 30 RFU.  The loci targeted in the Globalfiler™ kit can be 
found in Table A. 
2.2 Sequencing Workflow and Analysis 
As seen in Figure 3, extraction and quantification of samples follows the same 
procedures as standard DNA analysis of STRs using CE, but begin to vary at the 
amplification step.  Following the ForenSeq™ DNA Signature Prep Reference Guide [45] 
Figure 2.  Capillary electrophoresis workflow.  The average amount of time 
required to generate a DNA profile using CE. 
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“Procedure for Purified DNA,” a sample sheet was prepared to record the position of each 
sample, the controls, and index adapters; each well of the PCR plate (FSP) received 10 µl 
master mix [4.7 µl PCR1, 0.3 µl FEM, 5.0 µl DPMA].  Quantified samples were diluted 
down to 0.2 ng/µl using nuclease-free water, then 5 µl of each diluted sample was added 
to the appropriate well for an amplification target of 1 ng human genomic DNA (gDNA) 
input.  When each sample was properly prepared, they were placed on the GeneAmp® 
PCR System 9700 thermal cycler and run on the PCR1 procedure:  98℃ for 3 minutes, 8 
cycles of [96℃ for 45 seconds, 80℃ for 30 seconds, 54℃ for 2 minutes, 68℃ for 2 
minutes], 10 cycles of [96℃ for 30 seconds, 68℃ for 3 minutes], 68℃ for 10 minutes, 
then an indefinite hold at 10℃. 
The second amplification step, enrichment of targets (PCR2), takes place after 
PCR1 and involves the addition of Index 1 (i7) and Index 2 (i5) adapters to the target 
sequences.  The FSP was removed from the thermal cycler and centrifuged at 1000 x g for 
30 seconds.  Following the sample sheet previously prepared, 4 µl of i7 adapter was added 
to each sample-containing well within a column, and 4 µl of i5 adapter was added to each 
sample-containing well within a row.  Each well received 27 µl of the PCR2 reagent, 
centrifuged at 1000 x g for 30 seconds, and placed on the thermal cycler for the PCR2 
program run:  98℃ for 30 seconds, 15 cycles of [98℃ for 20 seconds, 66℃ for 30 seconds, 
68℃ for 90 seconds], 68℃ for 10 minutes, and an indefinite hold at 10℃. 
Following sample amplification and tagging, the samples are purified of reaction 
components using Sample Purification Beads.  The FSP is removed from the thermal cycler 
and centrifuged at 1000 x g.  Each well of a midi plate (PBP) receives 45 µl of SPB.  Then, 
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following the sample sheet, 45 µl of enriched sample is transferred from the FSP to the 
corresponding well of the PBP.  The plate was sealed with Microseal B and shaken for 2 
minutes at 1800 rpm, incubated at room temperature for 5 minutes, then placed on a 
magnetic stand and allowed time for the liquid to clear.  The beads were visibly clustered 
along the well wall closest to the magnet.  All supernatant was removed from the wells and 
discarded.  From there, a wash procedure was performed twice with the following steps: 
add 200 µl freshly prepared 80% EtOH to each well, incubate on magnetic stand for 30 
seconds, remove and discard all supernatant.  The plate was then centrifuged at 1000 x g 
for 30 seconds, placed back on the magnetic stand and residual EtOH was removed with a 
pipette.  The plate was taken off the magnetic stand and the beads were resuspended using 
52.5 µl RSB in each well.  The plate was sealed with Microseal B, shaken at 1800 rpm for 
2 minutes until the beads were sufficiently resuspended, incubated at room temperature for 
2 minutes, then placed back on the magnetic stand until the liquid was clear.  50 µl of the 
supernatant was transferred to the corresponding wells of a new PCR plate (PLP).  Lastly, 
the PLP was centrifuged at 1000x g for 30 seconds. 
To normalize the libraries, a master mix was prepared [46.8 µl LNA1 and 8.5 µl 
LNB1, per sample], vortexed, then 45 µl of the master mix was added to the appropriate 
well of the NWP (midi plate) that will contain a sample.  Following the sample sheet, 20 
µl of each sample was transferred from the PLP to the corresponding well of the NWP. 
The plate was sealed with Microseal B and shaken at 1800 rpm for 30 minutes.  While the 
NWP was shaking, 0.1 N HP3 was prepared in a 1.5 ml microcentrifuge tube by combining 
33.3 µl of nuclear-free water per sample with 1.8 µl HP3 per sample and inverting the tube 
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several times to mix.  According to the sample sheet, a new PCR plate (NLP) was prepared 
by adding 30 µl LNS2 to each well that will hold a library.  When the NWP was finished 
shaking, it was immediately placed on the magnetic stand until the liquid was clear and the 
supernatant was removed and discarded.  The plate was taken off the magnetic stand and 
another two wash steps were performed: add 45 µl LNW1 to each well, seal plate with 
Microseal B, shaken at 1800 rpm for 5 minutes, place plate on magnetic stand, remove and 
discard clear supernatant.  After washing, the plate was taken off the magnetic stand, 
centrifuged at 1000 x g for 30 seconds, placed back on the magnetic stand until clear and 
any remaining supernatant was removed.  Then, 32 µl of the freshly prepared 0.1 N HP3 
was added to each well.  The NWP was sealed and shaken at 1800 rpm for 5 minutes to 
resuspend the beads, then the plate was placed back on the magnetic stand until the liquid 
was clear.  Finally, 30 µl of each sample-containing supernatant was transferred from the 
NWP to the corresponding well on the NLP and mixed by pipetting.  One last centrifugation 
at 1000 x g for 30 seconds was performed. 
Before being placed on the MiSeq FGx™ instrument, the libraries need to be pooled 
and denatured.  To pool, 5 µl of each library was transferred directly into the 1.5 ml 
microcentrifuge tube labeled PNL tube, then vortexed and centrifuged briefly.  Denaturing 
and diluting the libraries should only be performed immediately before running the 
instrument, no earlier.  A human sequencing control (HSC) was created in the HSC mixture 
tube by combining 2 µl HSC, 2 µl HP3, and 36 µl nuclear-free water.  The HSC tube was 
vortexed and centrifuged briefly, then incubated at room temperature for 5 minutes. 
Another 1.5 ml microcentrifuge tube was labeled DNL and 591 µl HT1 was added, 
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followed by 7 µl of the pooled libraries from the PNL tube.  2 µl of the HSC mixture was 
added to the PNL tube, pipetted to mix, then briefly vortexed and centrifuged.  The PNL 
tube was heated at 96℃ for 2 minutes, inverted several times, then immediately placed in 
an ice-water bath for 5 minutes.  The entire volume of the PNL tube was immediately 
loaded onto the reagent cartridge, placed on the instrument, and the sequencing run was 
performed.  Results were available for analysis approximately 24 hours later. 
Sequencing results were analyzed using the ForenSeq™ Universal Analysis 
Software version 1.3.6767 (Verogen, Inc., San Diego, CA) using Verogen’s preset AT, IT, 
and stutter percentages.  Each sample was individually analyzed to ensure allele calls from 
UAS matched the allele calls from GeneMapper®.  The loci sequenced using the 
ForenSeq™ kit can be found in Table A [45]. 
Figure 3.  Sequencing workflow.  Sequencing using the MiSeq FGx™ and the 
ForenSeq™ Prep kit shares similar workflow to CE up until the first PCR step. 
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2.3 Sample Mixture Preparation and Analysis 
To create the best mixture, a male sample and an unrelated female sample were 
chosen based on having a good balance between shared and unshared alleles.  The presence 
of isoalleles, also known as isometric alleles, provides additional information when using 
UAS, therefore extra weight was placed on the presence of isoalleles for choosing samples.  
Initially, genotypes of all samples from GeneMapper® were added to an excel sheet to be 
compared against one another.  Unfortunately, CE-based methods cannot identify 
isoalleles, so STR loci were ranked based on their power of discrimination to increase the 
probability that isoalleles will be present [46].  Shared alleles at loci with higher 
discriminatory power were given greater weight when considering the best samples for a 
mixture.  After analyzing CE data on GeneMapper®, samples 443 and 458 were chosen to 
be the best option for a mixture.  However, samples 444 and 456 were determined to be 
the best option for generating mixtures after comparing the sequenced samples on the UAS, 
because the UAS offers the ability to differentiate samples based on their sequences and 
visualize the isoalleles present.  Furthermore, the UAS has a feature that allows for side-
by-side comparison of the sequence of two samples. 
Based on Michael Moretto’s previous research on mixture interpretation using the 
MiSeq FGx™ [47] and other research papers reviewed [48,49], mixtures were made in 
ratios of 1:1, 1:4, and 1:10 in replicates of four, as minor contributors are difficult to 
observe in mixture ratios greater than 1:10, though possible.  Samples 444 and 456 were 
quantified in triplicate and the volumes of each sample needed for each mixture ratio were 
calculated for a final concentration of 0.2 ng/µl in a total volume of 100 µl.  Mixtures were 
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created with female sample 456 as the major contributor using the following masses of 
DNA from sample 444 and 456, respectively: 1:1 (10 ng and 10 ng), 1:4 (4 ng and 16 ng), 
and 1:10 (1.8 ng and 18.2 ng).  After the mixtures were made, four replicates of each 
mixture ratio were amplified in Globalfiler™ and separated on CE using the protocols 
outlined previously.  The mixture profiles were then analyzed in GeneMapper®.  Four 
replicates of each mixture were also amplified and sequenced following the MiSeq FGx™ 
protocols previously outlined and analyzed on the UAS.  The workflow for this study is 
outlined in Figure 4 below. 
The formulas used to calculate the contributor ratios seen in the CE (RFU) and 
MiSeq FGx™ (ARC) data are found in Table 1.  Amelogenin, Y-Indel, and DYS391 were 
excluded from calculations; only autosomal STR loci were used in calculations.  Loci were 
included in calculations if the following combinations of alleles were present:  two 
heterozygous contributors with no shared alleles, two heterozygous contributors with a 
Figure 4.  Outline of research workflow.  Steps in orange boxes with blue 
outlines took place prior to amplification.  Steps in blue boxes are specific for the 
CE workflow.  Steps in Orange boxes are specific to the sequencing workflow. 
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shared allele, one homozygous and one heterozygous contributor with no shared alleles, or 
two homozygous contributors with no shared alleles.  If there was a shared allele at a locus, 
the shared allele was removed from the calculation and only the unshared alleles were used 
to determine the contributor ratio.  Loci were not included in calculations if the following 
combinations of alleles were present:  two heterozygous contributors but only two peaks 
present, two homozygous contributors with the same alleles, or any loci with allelic drop 
out.  Alleles that do not pass AT are not called by the UAS and are considered as a drop 
out allele; therefore, loci that had an allele(s) that did not pass AT were not used in the 
calculations. 
For all replicates, these calculations were performed at each locus that met the 
appropriate criteria.  Using all four replicates, the mean contributor ratio for each individual 
locus was calculated.  Then, the total mean contributor ratio across all four replicates of 
each mixture ratio was calculated.  The standard deviation of each mean was also calculated 
Table 1.  Equations used for contributor ratio calculations.  𝜑 refers to the 
RFU (CE) or the ARC (MiSeq FGx™) of each corresponding allele. 
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and reported alongside the mean or visualized as error bars in the bar graphs, and overall 
distributions across each mixture ratio are displayed in boxplots (Figures 5-12). 
2.3.1 GeneMapper® Analysis of Mixture Profiles 
The EPGs were analyzed on GeneMapper® with an AT of 30 RFU and stutter filter 
on.  Each of the replicates were individually analyzed and compared against the genotypes 
from the known single source profiles to determine the accuracy of the results and calculate 
contributor ratios of the mixture profiles.  Contributor ratios were calculated based on RFU 
using the formulas in Table 1.  Microsoft Excel 2016 was used to perform contributor ratio 
calculations at each locus in all replicates.  Each locus was attributed a mean contributor 
ratio with standard deviation using the data from the corresponding locus over all four 
replicates.  The total mean contributor ratio and standard deviation for each mixture was 
calculated using the mean contributor ratios for each locus.  To visualize the data, bar 
graphs were prepared using JMP Pro 15 and can be found in the Results section. 
2.3.2 UAS Analysis of Mixture Profiles 
The mixture profiles generated using the MiSeq FGx™ System were analyzed on 
the UAS with the software’s preset AT (1.5%), IT (4.5%), and stutter percentages that vary 
between loci.  Each replicate was compared against the single source profiles from 
GeneMapper® and UAS to ensure proper allele calls before performing contributor ratio 
calculations on Excel.  Contributor ratio calculations and standard deviation calculations 
were performed in the same manner for the Globalfiler™ mixtures.  Only autosomal STRs 
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were included in calculations.  Bar graph generation on JMP was also performed similarly 
to Globalfiler™ mixtures.  However, there were some differences in analysis between the 
two systems.  For UAS, ARC was used instead of RFU in calculations.  Alleles of same 
length but different sequence were included in the calculations if they could be attributed 
to a specific contributor.  Furthermore, stutter within true allele peaks that could be 
differentiated by sequence was subtracted from calculations when appropriate. 
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3. RESULTS
3.1 Single Source Profiles and Sample Selection 
Single source profiles were generated on the CE and MiSeq FGx™ and analyzed 
on GeneMapper® and UAS, respectively.  Genotypes for each individual were recorded in 
Excel and analyzed with the intent of finding an unrelated male and female that had high 
heterozygosity and an ideal balance of loci with shared and unshared alleles (at least >50% 
of loci have shared alleles) in order to maximize the probability of isoallele presence 
without hindering contributor ratio calculations and having too many loci with shared 
alleles.  Only autosomal STR loci were considered; Amelogenin, Y-Indel, and DYS391 
were excluded from the analysis.  GeneMapper® profiles (21 autosomal STR loci) were 
analyzed first to determine the best subjects to use for mixture, with loci categorized based 
on their discriminatory power determined in previous studies [26] in the order of most 
discriminating, highly discriminating, moderately discriminating, and least discriminating.  
Individuals 443 and 458 were determined to be best fit for mixtures by having shared alleles 
at 2 most, 10 highly, 3 moderately, and 0 least discriminating loci; among the loci with 
shared alleles for samples 443 and 458, 11 were heterozygous and 4 were homozygous.  
However, UAS sequencing data proved to be more beneficial than GeneMapper® and was 
used in generating the mixtures.  While GeneMapper® data showed that samples 444 and 
456 have shared alleles at only 2 most, 6 highly, 1 moderately, and 1 least discriminating 
loci, with 7 heterozygous and 3 homozygous shared alleles, they were chosen to make 
mixtures because they have 3 instances of isoalleles, compared to the 2 isoalleles between 
samples 443 and 458. 
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3.2 Capillary Electrophoresis Mixture Profiles 
3.2.1 1:1 Mixtures 
The 1:1 mixture was prepared using quantification results to have equal amount of 
the 444 and 456 contributors’ DNA (10 ng each).  The calculated contributor ratio was 
1.040 + 0.311 (n=64 loci).  Each replicate had 16 loci suitable for calculation following the 
criteria previously outlined; there was no dropout observed over all four replicates.  The 
mean contributor ratios for each of the 16 loci are displayed as a bar graph, with error bars 
showing the intra-locus variability (Figure 5).  No locus has a mean contributor ratio that 
was an outlier, as shown by the box plot in Figure 8. 
Figure 5.  Mean contributor ratios per Globalfiler™ locus across four replicates 
of 1:1 CE mixtures.  Blue bars represent the mean contributor ratio for each locus 
over all four replicates. Purple line represents total mean contributor ratio over 
all four replicates. One standard deviation per locus is shown as error bars. 
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3.2.2 1:4 Mixtures 
The 1:4 mixtures were prepared using the quantification results to be one-part 
sample 444 DNA and four parts sample 456 DNA (4 ng and 16 ng, respectively).  The 
calculated total mean contributor ratio was 4.678 + 2.093 (n=62) and the standard deviation 
increased compared to the 1:1 mixture.  There were two instances of minor contributor 
allele dropout in the 1:4 mixture samples.  Dropout was observed in replicates A and D at 
D12S391 (17.3 allele and 17 allele, respectively).  Replicates B and C had 16 loci suitable 
for calculations following the criteria previously outlined, and replicates A and D each had 
15 loci suitable for calculations.  The mean contributor ratios for each of the 16 loci are 
displayed as a bar graph, with error bars showing the intra-locus variability (Figure 6).  No 
locus has a mean contributor ratio that was an outlier (Figure 8).  
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3.2.3 1:10 Mixtures 
The 1:10 mixtures were prepared using the quantification results to be one-part 
sample 444 DNA and ten parts sample 456 DNA (1.8 ng and 18.2 ng, respectively).  The 
calculated total mean contributor ratio was 9.311 + 3.363 (n=62) the standard deviation 
increased compared to the lower mixtures.  There were 11 instances of minor contributor 
allele dropout in the 1:10 mixture samples.  Replicates A, B, and D each had three instances 
of dropout, and replicate C had two instances of dropout.  Dropout was observed in 
replicate A at D1S1656 (17 allele), D12S391 (17.3 allele), and SE33 (15 allele).  Dropout 
was observed in replicate B at D12S391 (17.3 allele), D18S51 (20 allele), and SE33 (29.2 
allele).  Dropout was observed in replicate C at D1S1656 (17 allele), and D12S391 (17.3 
Figure 6.  Mean contributor ratios per Globalfiler™ locus across four replicates 
of 1:4 CE mixtures.  Blue bars represent the mean contributor ratio for each locus 
over all four replicates. Purple line represents total mean contributor ratio over 
all four replicates. Standard deviation per locus is included as error bars. 
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allele).  Dropout was observed in replicate D at D1S1656 (17 allele), D12S391 (17.3 
allele), and D16S539 (11 allele).  All instances of dropout are summarized in Table 6.  
Replicates A, B, and D each had 13 loci suitable for calculations following the criteria 
previously outlined, and Replicate C had 14 loci suitable for calculations.  Dropout at 
D12S391 in each of the four replicates resulted in the complete loss of the locus from total 
mean contributor calculations.  The mean contributor ratios for each of the 15 loci are 
displayed as a bar graph, with error bars showing the intra-locus variability (Figure 7). 
Locus D1S1656 has a standard deviation of zero, because there was only one replicate for 
this locus available for calculations.  No locus has a mean contributor ratio that was an 
outlier, as shown by the box plot in Figure 8. 
Figure 7.  Mean contributor ratios per Globalfiler™ locus across four 
replicates of 1:10 CE mixtures.  Blue bars represent the mean contributor ratio 
for each locus over all four replicates. Purple line represents total mean 
contributor ratio over all four replicates. Standard deviation per locus is 
included as error bars. 
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In Figure 8 below, the distribution of contributor ratio values (as calculated for each 
locus) are displayed as boxplots aligned side-by-side for a comparison of the three mixture 
ratios.  The standard deviation and range of values increases as the mixture ratio increases. 
3.3 MiSeq FGx™ Mixture Profiles 
The ForenSeqTM DNA Signature Prep Reference Guide [25] cautions interpretation of 
D22S1045 and D7S820.  Locus D22S1045 may display elevated n-1 stutter and have 
heterozygote imbalance regardless of coverage.  Locus D7S820 may have a low-level .1 
bp artifact belonging to the parent allele (e.g., an 11 allele may show an 11.1 artifact with 
low intensity).  Both of these properties were observed at these loci for all samples.  Alleles 
Figure 8.  Variation within each CE mixture ratio.  Boxplots of contributor ratios 
for each locus, averaged over four replicates, in the 1:1, 1:4, and 1:10 mixtures.  
The contributor ratio mean and range is displayed above the boxplot for the 
respective mixture. 
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that did not pass AT are differentiated from alleles that completely dropout from the profile, 
but are still counted as dropout because alleles that do not pass AT are generally not 
interpreted [13,28]. 
There were autosomal STR isoalleles observed at D8S1179, D9S1122, and D13S317 
(Table 2) with an additional isoallele at a X chromosome STR locus (DXS10135).  Only 
autosomal STRs were analyzed in this study, but this additional locus may further improve 
contributor calculations and interpretation.  The three STR isoalleles were observed in all 
replicates and aided in the calculation of contributor ratios.  The isoalleles showed equal 
intra-locus variation compared to other heterozygous alleles in the 1:1 and 1:4 mixtures, 
but D9S1122 and D13S317 showed increased intra-locus variation compared to most of 
the other heterozygous loci in the 1:10 mixture.  The mixture sequencing run was within 
optimal range for all quality metrics, as summarized in Table 3.  
Table 2. Isoalleles between contributor 444 and 456. 
Table 3. Quality Metrics for the mixture sequencing run. 
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3.3.1 1:1 Mixtures 
The total mean contributor ratio of this mixture based on MiSeq FGx™ data was 
1.144 + 0.344 (n=88 loci).  Each replicate had 22 loci suitable for calculation following the 
criteria previously outlined; there was no dropout observed over all four replicates.  The 
mean contributor ratios for each of the 22 loci are displayed as a bar graph, with error bars 
showing the intra-locus variability (Figure 9).  The mean contributor ratio for locus 
D17S1301 is an outlier, as shown by the box plot in Figure 12. 
Figure 9.  Mean contributor ratios per ForenSeq™ locus across four replicates 
of 1:1 MiSeq FGx™ mixtures.  Orange bars represent the mean contributor ratio 
for each locus over all four replicates. Green line represents total mean 
contributor ratio over all four replicates. Standard deviation per locus is included 
as error bars. 
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3.3.2 1:4 Mixtures 
The total mean contributor ratio of this mixture based on MiSeq FGx™ data was 
4.033 + 1.506 (n=87 loci).  Replicates A, B, and C had 22 loci suitable for calculation 
following the criteria previously outlined, and due to the loss of a minor allele, replicate D 
had 21 loci suitable for calculations.  The 8 allele at Penta E did not pass AT for that locus 
and therefore was not used in the calculations.  The mean contributor ratios for each of the 
22 loci are displayed as a bar graph, with error bars showing the intra-locus variability 
(Figure 10).  Locus D17S1301 has a mean contributor ratio that was an outlier, as shown 
by the box plot in Figure 12.  
Figure 10.  Mean contributor ratios per ForenSeq™ locus across four replicates 
of 1:4 MiSeq FGx™ mixtures.  Orange bars represent the mean contributor ratio 
for each locus over all four replicates. Green line represents total mean 
contributor ratio over all four replicates. Standard deviation per locus is included 
as error bars. 
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3.3.3 1:10 Mixtures 
The total mean contributor ratio of this mixture based on MiSeq FGx™ data was 
10.347 + 5.184 (n= 76 loci).  There were 10 instances of minor contributor alleles not 
passing AT, and 4 instances of complete minor contributor allele dropout in the 1:10 
mixture samples.  Due to the loss of these alleles, replicates A and D had 18 loci, replicate 
B had 21 loci, and replicate C had 19 loci suitable for calculation following the criteria 
previously outlined.  In replicate A, loci that had alleles that did not pass AT include 
D6S1043 (19 allele), D13S317 (13 allele), Penta D (13 allele), and Penta E (8 allele); the 
13 allele at Penta E completely dropped out.  In replicate B, the 9 allele at Penta D 
completely dropped out.  In replicate C, loci that had alleles that did not pass AT include 
D16S539 (11 allele) and Penta D (13 allele); the 13 allele at Penta E completely dropped 
out.  In replicate D, loci that had alleles that did not pass AT include D18S51 (20 allele), 
D19S433 (15 allele), and S21S11 (28 and 33.2 alleles); the 8 allele at Penta E completely 
dropped out.  The mean contributor ratios for each of the 22 loci are displayed as a bar 
graph, with error bars showing the intra-locus variability (Figure 11).  Loci Penta D and 
Penta E both have standard deviations of zero, because there was only one replicate for 
each locus available for calculations.  No locus has a mean contributor ratio that was an 
outlier, as shown by the box plot in Figure 12. 
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For the MiSeq FGx™ data, the distribution of the contributor ratio values (as 
calculated for each locus) for the three mixture ratios are displayed as boxplots for a side-
by-side comparison (Figure 12).  The standard deviation and range for the MiSeq FGx™ 
1:10 mixture increased compared to the CE data. 
Figure 11.  Mean contributor ratios per ForenSeq™ locus across four replicates 
of 1:10 MiSeq FGx™ mixtures.  Orange bars represent the mean contributor 
ratio for each locus over all four replicates. Green line represents total mean 
contributor ratio over all four replicates. Standard deviation per locus is included 
as error bars. 
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3.4 CE versus MiSeq FGx™ 
3.4.1 Comparison of Shared Autosomal Loci 
Using the 20 autosomal STR loci shared between the two amplification kits used 
for each analysis method (Table A), a total mean contributor ratio and total standard 
deviation was calculated for both the CE and MiSeq FGx™ data at each mixture ratio, as 
summarized in Table 4 below.  Additional data comparing the range of values were shown 
previously in boxplots (Figures 8 and 12).  The main difference observed was that the 
standard deviation and range for the 1:10 mixture increases compared to the 1:1 and 1:4 
mixtures. 
Figure 12.  Variation within each MiSeq FGx™ mixture ratio.  Boxplots of 
contributor ratios for each locus, averaged over four replicates, in the 1:1, 1:4, and 
1:10 mixtures.  The contributor ratio mean and range is displayed above the 
boxplot for the respective mixture.  Outlier loci (D17S1301) are labeled as a red 
“X.” 
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The only locus from the Globalfiler™ amplification kit for CE that was not in the 
sequencing kit was SE33.  Of the 20 loci shared between the two amplification kits, the CE 
data had 15 loci and the MiSeq FGx™ data had 16 loci suitable for calculations following 
the criteria previously outlined.  Locus D13S317 contained the 11a and 11b isoalleles that 
could be observed on the MiSeq FGx™, but not the CE data, providing the additional locus 
available for calculations.  Neither method had outlier loci amongst the 20 shared 
autosomal STR loci (Figures 8 and 12). 
The CE versus MiSeq FGx™ comparison of mean contributor ratios per locus for 
the 1:1 mixture are displayed in Figure 13.  The CE data had three loci (D2S441, D16S539, 
and D19S433) with error bars greater than the standard deviation for the mixture.  The 
MiSeq FGx™ data had two loci (CSF1PO and TH01) with error bars greater than the 
standard deviation for the mixture.  
Table 4.  Mean contributor ratios for CE and MiSeq FGx™ using shared 
autosomal STR loci.  The total means with standard deviations for each mixture 
ratio are displayed to compare the two analysis methods.  Means and standard 
deviations were calculated using the autosomal loci shared between the two 
methods. 
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The CE versus MiSeq FGx™ comparison of mean contributor ratios per locus for 
the 1:4 mixture are displayed in Figure 14.  The CE data had three loci (D2S1338, D18S51, 
and TH01) with error bars greater than the standard deviation for the mixture.  The MiSeq 
FGx™ data had two loci (D2S441 and D3S1358) with error bars greater than the standard 
deviation for the mixture.  Among the 20 shared autosomal loci, the CE data had two 
instances of dropout at locus D12S391, once in Replicate A and once in Replicate D.  There 
were no instances of minor allele dropout in the MiSeq FGx™ data. 
Figure 13.  Comparison of mean contributor ratio per locus at shared autosomal 
STR loci for the 1:1 mixtures on the CE versus MiSeq FGx™. 
39 
The CE versus MiSeq FGx™ comparison of mean contributor ratios per locus for 
the 1:10 mixture are displayed in Figure 15.  The CE data had one locus (D16S539) with 
error bars greater than the standard deviation for the mixture.  The MiSeq FGx™  data had 
four loci (D2S44, D13S317, D16S539, D18S51, and D3S1358) with error bars greater than 
the standard deviation for the mixture.  Among the 20 shared autosomal loci, the CE data 
had nine instances of minor allele dropout over the four replicates, and the MiSeq FGx™ 
data had six instances of minor allele dropout. 
Figure 14.  Comparison of mean contributor ratio per locus at shared autosomal 
STR loci for the 1:4 mixtures on the CE versus MiSeq FGx™. 
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Figure 16 below shows a comparison of the CE and MiSeq FGx™ mean contributor 
ratios for each mixture.  In the 1:1 mixture, both methods showed identical results.  In the 
1:4 mixture, the MiSeq FGx™ data was closer to the target ratio with a lower standard 
deviation compared to the CE data.  In the 1:10 mixture, the MiSeq FGx™ data had a larger 
standard deviation than CE. 
Figure 15.  Comparison of mean contributor ratio per locus at shared autosomal 
STR loci for the 1:10 mixtures on the CE versus MiSeq FGx™. 
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3.4.2 Full comparison of Autosomal STR Amplification Kits 
A full Globalfiler™ amplification kit targets 21 autosomal STR loci, but only 16 
loci were available for contributor calculations.  The MiSeq FGx™ targets 27 autosomal 
STR loci, but 22 loci were available for calculations.  Table 5 shows the CE and MiSeq 
FGx™ values using all available STR loci for contributor calculations.  The only locus that 
had to be removed from the Globalfiler™ kit for the CE versus MiSeq FGx™ comparison 
was SE33.  When comparing the values in Table 4 with Table 5 the removal of SE33 from 
calculations resulted in lower values for the standard deviation at all mixture ratios, 
especially at the 1:10 mixture ratio.  The MiSeq FGx™ also saw similar decreases in 
Figure 16.  Mean contributor ratios for CE and MiSeq FGx™.  The mean 
contributor ratios, averaged over four replicates, for the 1:1, 1:4, and 1:10 
mixtures displayed side-by-side.  The standard deviation for each mixture is 
displayed as error bars. 
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variation.  However, both methods were further from the target ratios in the 1:10 mixtures 
when only comparing the shared autosomal STR loci.  
Table 5.  Mean Contributor Ratios for CE and MiSeq FGx™ using all 
autosomal STR loci.  The total means with standard deviations for each mixture 
ratio are displayed to compare the two analysis methods.  Means and standard 




All the isoalleles observed in this study have previously been reported in the 
National Institute of Science and Technology (NIST) database [50,51].  Additional 
previous NGS research [31,52,53] has revealed novel alleles, or isoalleles that have not 
been previously reported in the literature, at the common loci used for forensic DNA 
analysis.  The number of alleles has doubled at some loci due to alleles based on sequence 
rather than length.  While different sequencing systems and analysis software have some 
variation in the sequence-based alleles observed, most have revealed significant increases 
(>25) in alleles at D2S1338, D12S391, and D21S11, as well as moderate increases (<25) 
in other loci.  On the other hand, some systems have revealed novel alleles at loci when 
other kits reported no new novel alleles.  For example, the PowerSeq Auto System [31] 
revealed novel alleles at CSF1PO, D1S1656, and D18S51 while the 454 sequencing 
platform [54] failed to find any new alleles at these loci. 
More novel alleles were discovered in previous studies by analyzing the FR as well 
as the RR [52].  Some loci have not shown any novel alleles in their RR, but have shown 
variation in their FR.  The ability to detect FR variation is reliant upon primer position and 
the analysis software utilized.   For example, no novel alleles were found at D13S317 using 
the PowerSeq™ or 454, but were found in the FR using the MiSeq FGx™ [32].  Additional 
novel alleles were discovered based on FR alone at D22S1045 and D7S820.  Other loci 
showed novel alleles in both the RR and FR.  Variation in the FR may lead to an increase 
in microvariants, as commonly seen in D7S820 with the single addition of a T nucleotide 
to a poly(T) stretch in the flanking region [55,56].  The only way to detect these FR 
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variations, other than by sequencing, is by base composition analysis using mass 
spectrometry [57,58]. 
4.1 CE versus MiSeq FGx™ Mixtures 
RT-PCR quantification data was used to calculate the volume of each sample 
needed to create the targeted mixture ratios of 1:1, 1:4 and 1:10 with a concentration of 0.2 
ng/µL.  MiSeq FGx™ contributor ratios were in concordance with the target ratios.  
However, CE results showed that the 1:4 and 1:10 intended ratios were closer to 1:4.5 and 
1:9, respectively.  Concerns over increased amplification bias on the MiSeq FGx™ due to 
the increased amount of amplification steps has not been reported by independent literature 
or Verogen’s internal validation and does not appear to have occurred in this study.  Overall 
the MiSeq FGx™ resulted in more accurate calculations due to the higher number of loci 
analyzed by targeting more loci, generating more complete minor profiles (Table 6), 
identification of isoalleles, and differentiation of true alleles from stutter (Table 7).   
For the direct comparison of autosomal STR loci shared between the two 
amplification kits, the MiSeq FGx™ had less instances of dropout.  For CE, dropout began 
at the 1:4 mixture with two total instances of dropout, both at D12S391 in replicates A and 
D. For the MiSeq FGx™, dropout did not occur until the 1:10 mixture.  For the 1:10 CE
mixture, there were nine instances of dropout observed, compared to the six instances of 
dropout in the MiSeq FGx™ data.  Out of the 12 mixture profiles analyzed, CE was only 
able to generate six complete profiles for the minor contributor.  The MiSeq FGx™ was 
able to generate nine complete profiles for the minor contributor. 
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When comparing the two analysis methods using all available autosomal STR loci 
targeted by the amplification kits, the MiSeq FGx™ had more instances of dropout yet still 
performed better than CE.   Nothing changed for the CE data, where dropout began at the 
1:4 mixture with two total instances of dropout, both at D12S391 in replicates A and D.  
For the 1:4 mixture on the MiSeq FGx™, one allele dropped out at Penta E in replicate D. 
For the 1:10 CE mixture, there were 11 instances of dropout observed.  In the 1:10 MiSeq 
FGx™ mixture there were 14 total instances of allele dropout.  With a total of 13 dropouts 
in the CE data, that is a loss of approximately 3.4% of all possible alleles.  Comparatively, 
the total of 15 alleles lost in the MiSeq FGx™ is approximately 2.84% of all possible 
alleles.  Only one locus, SE33, was added to the calculations for CE and the total number 
of dropout increased by two; the MiSeq FGx™ had an additional 6 loci included, yet only 
had two more total instances of dropout than CE.  Even with more total instances of 
dropout, the MiSeq FGx™ was still able to generate more complete profiles for the minor 
contributor. 
A distinction should made between the methods used by GeneMapper® and UAS 
for the establishment of AT.  GeneMapper® uses a fixed value for the AT at all loci, 
whereas the UAS bases the AT at an individual locus on a percent value (1.5%) based on 
Table 6. Comparison of Dropout between CE and MiSeq FGx™.  Values for CE 
are highlighted in blue.  Values for MiSeq FGx™ are highlighted orange. 
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the total number of reads at that locus.  This is important for larger mixture ratios (e.g. 
1:10), when the major contributor will have a significantly larger ARC than the minor 
contributor, and may therefore mask the minor contributor peaks with an AT that is too 
high.  However, the UAS provides the option to manually change the thresholds for 
individual loci, while software like GeneMapper® only allowed the analyst to alter the AT 
for the entire profile.  With proper validation studies on mixture samples, laboratories may 
determine the circumstances when it is appropriate to decrease the AT when it is 
determined an analyst is working with a large mixture ratio, thus preventing a false negative 
for minor allele calling without increasing the risk of false positives at the other loci. 
 The MiSeq FGx™ also revealed three sequence-based heterozygotes (D8S1179, 
D9S1122, and D13S317) that appeared to be homozygous alleles in the CE data, providing 
additional data for calculations.  Additionally, the MiSeq FGx™ was able to separate 
certain true allele ARCs from the stutter of another allele based on sequence, which 
provided more accurate values to be used in calculation.  Using the MiSeq FGx™ data, 
this stutter differentiation was possible at D2S1338, D3S1358, D5S818, and D21S11 
(Table 7).  It is important to note that while the sequencing data can differentiate true alleles 
from stutter for certain alleles, it cannot do it for all alleles.  Differentiation can only occur 
if the two parent alleles have different sequences; if the alleles are different lengths but 
have the same sequence, the stutter will have the same sequence as well.  Furthermore, 
stutter was not consistently differentiated from true alleles.  Stutter at D2S1338, D3S1358, 
and D21S11 was differentiated for all four replicates in each mixture.  However, for 
D5S818, stutter was differentiated for the 1:4 and 1:10 mixtures, but not the 1:1 mixture.  
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This is due to the genotypes of the major and minor contributors at this locus (11,12 and 
11,11, respectively).  For the 1:1 mixture, contributors were present in equal amounts and 
the shared 11 alleles peak was much larger than the lone 12 allele peak.  As the mixture 
ratio increased, the major contributor’s 12 allele was present in high enough concentration 
to produce visible stutter at the 11 position. 
 
It is also important to note that while the isoallele at D13S317 was helpful for 
contributor calculation, it may be less helpful in casework when the profiles of the 
contributors are unknown.  As shown in Table 2, the isoallele belongs to contributor 456’s 
homozygous 11 allele.  When an analyst cannot refer to reference profiles, they may be 
tempted to assign 11a to contributor 444 and 11b to contributor 456, when in reality the 
profiles are as follows:  11a is a shared allele between the two contributors and 11b is the 
isoallele of contributor 456.  The presence of intra-contributor isoalleles may cause 
Table 7.  Sequence differences between true alleles and stutter in the mixture 
samples. 
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uncertainty in the interpretation of an STR locus and should be considered when using 
sequencing mixture data.  Assignment of alleles to specific contributors may not be 
possible at the 1:1 ratio, but has improved accuracy in higher ratios.  If approached with 
caution, keeping in mind the known loci with increased rates of heterozygote imbalance, 
utilizing appropriate thresholds to estimate the probability of allele dropout, and comparing 




 Illumina’s MiSeq FGx™ System in combination with Verogen’s Signature Prep kit 
has proven in this paper, along with others [49,52], to provide more information than CE 
using the Globalfiler™ PCR amplification kit.  Multiplexing autosomal, X- and Y-STRs, 
and SNPs in a single reaction increases the amount of information available for individual 
identification in forensic cases.  Even when only shared STR loci between the two kits are 
compared, sequencing provides more information with the ability to visualize isoalleles 
and differentiate stutter from true alleles.  When comparing the loci shared between the 
two amplification kits, CE had more instance of allele dropout and the MiSeq FGx™ 
generated more complete profiles for the minor contributor.  When comparing all the loci 
available in the amplification kits, the MiSeq FGx™ targets six additional loci yet only had 
two additional instances of dropout compared to CE.  Even with more instances of dropout, 
the MiSeq FGx™ was still able to generate more complete profiles for the minor 
contributor. 
Isoalleles in sequencing data helps determine the presence of a mixture and are 
most helpful in mixture ratios greater than 1:1.  Isoalleles are less helpful in 1:1 mixtures 
because they identify the presence of an allele that was otherwise concealed in CE data, 
but are not helpful in assigning alleles to a specific contributor.  Unfortunately, the possible 
presence of intra-contributor isoalleles at a locus may be misleading when attempting to 
interpret the profile.  The ability to differentiate stutter from true alleles helps in contributor 
ratio calculations and determining heterozygous matches during interpretation, which may 
prove valuable to forensic casework.  As larger population studies are performed, a better 
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estimate of isoallele frequency, and intra-contributor isoallele frequency, will improve 
interpretation of mixture samples.  Additionally, more studies performed on mixture 
samples will provide more information for setting specific thresholds for loci and improve 
interpretation of samples with larger mixture ratios. 
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6. FUTURE DIRECTIONS 
In this study, only autosomal STRs were analyzed, but it is important to utilize the 
MiSeq FGx™ System in all its potential.  In the future, it would be valuable to compare 
the autosomal STR data generated by the CE using Globalfiler™ against the autosomal 
STR, X-STR, Y-STR, and SNP data generated by the MiSeq FGx™.   These procedures 
should also be repeated with different mixture ratios, or higher-order mixtures such as 
three-person or four-person mixtures.  Isoalleles and stutter differentiation improved 
contributor ratio and peak height ratio calculations in this two-person mixture study, but 
how well do they improve these calculations in mixtures with more contributors?  
Additionally, future research might include analyzing mixtures with degraded DNA, where 
perhaps the use of SNPs would be more important than STR analysis. 
Another area worth researching in the future is amplification-free sequencing.  
Amplification bias has been a problem for CE and sequence analysis of mixtures and 
degraded samples.  Amplification is mostly present as bias towards a major over minor 
contributor, but there can also be bias towards specific sequences.  Bias towards specific 
sequences has been more often noted when analyzing SNPs, specifically in samples with 
high AT content.  Additionally, amplification and sampling biases during library 
preparation result in libraries that are lower in complexity than the genomic DNA from 
which they were derived.  The PCR amplification step may be avoided if an additional 
quantification step is performed; which, if using a NanoDrop 2000c spectrophotometer 
(Thermo Scientific) quantifier or something similar, may only take a few minutes.  Cluster 
52 
generation on the flow cell would act as the amplification step to provide sufficient sample 
for analysis [59]. 
This PCR-free procedure requires more research to prove reproducibility and 
efficacy in forensic cases, as they mostly deal with low concentration or degraded samples.  
It also requires PCR-free specific primers and adaptors to be made for it to work.  
Therefore, even if this procedure proves to be viable in forensic cases, it will likely not be 
applied in forensic laboratories until these PCR-free kits are commercially available.  
However, the elimination of a 3.5-hour step would make Illumina’s MiSeq FGx™ System 
an even stronger competitor against current CE-based analysis [59]. 
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APPENDIX A: TABLES OF LOCI AND CONTRIBUTOR GENOTYPES 
Table A.  Loci targeted in each analysis method.  Loci targeted for the CE-based 
analysis are from the Globalfiler™ PCR amplification kit.  Loci targeted by the 
MiSeq FGx™ are from the ForenSeq™ DNA Signature Prep Kit.  Loci 
unique to Globalfiler™ are highlighted blue.  Loci unique to MiSeq FGx™ are 
highlighted orange. 
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Table B.  Genotypes observed for mixture contributors on CE.  Loci used for 
contributor calculations are marked with a 𝜑. 
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Table C.  Genotypes observed for mixture contributors on MiSeq FGx™.  Loci 
used for contributor calculations are marked with a 𝜑.  Loci with isoalleles are 
marked with a *. 
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